Spirituality linked with better health outcomes, patient care
Spirituality should be incorporated into care for both serious illness and overall health, according to a study by Harvard Chan School and Brigham and Women’s Hospital.
Spirituality should be incorporated into care for both serious illness and overall health, according to a study by Harvard Chan School and Brigham and Women’s Hospital.
The Nurse-Family Partnership ® (NFP), a prenatal and early child home visiting program, did not improve birth outcomes for low-income mothers in South Carolina, according to a new, ongoing study.
Facing extreme weather events is impacting Americans’ views about the need for climate change action, according to a new NPR/Robert Wood Johnson Foundation/Harvard Chan School poll.
When accounting for miles traveled during biking, walking, or driving, Black and Hispanic Americans experience higher motor vehicle-related death rates than White Americans or Asian Americans.
Higher levels of optimism were associated with longer lifespan and living beyond age 90 in women across racial and ethnic groups in a study led by researchers at Harvard T.H. Chan School of Public Health.
A team at Harvard Chan School and Dana-Farber has launched a new website that provides accurate, reliable information about what does and does not cause cancer.
Cells use their molecular architecture to regulate their metabolic functions, and repairing diseased cells’ architecture to a healthier state can also repair metabolism, according to a study led by Harvard T.H. Chan School of Public Health researchers.
Two treatments that have been shown to be ineffective against COVID-19—hydroxychloroquine and ivermectin—were more heavily prescribed in U.S. counties with a higher Republican vote share in the 2020 presidential election, according to a new study.
Before lifting mask mandates in elementary schools in the U.S., local COVID-19 case rates should be far below current ones, according to a new study by Harvard Chan School and Massachusetts General Hospital.
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard Chan School.